Rep. Moore Introduces CBW Fentanyl Act to Sanction Foreign Officials Over Drug Precursor Chemicals
This bill is currently sitting in three different House committees for review. Nothing has happened with the bill since February 2026, which is a period of four months. It is not moving forward at this time because committees have not taken any action.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 8197 (118th), which died when its Congress ended.
H.R. 8197 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
U.S. businesses that import chemicals, scientific equipment, or biological products from a sanctioned country could face new procurement bans and export restrictions. Companies in the chemical supply chain or those relying on scientific cooperation with the targeted country would need to find alternative suppliers, raising costs.
“A prohibition on the procurement of, or entry into a contract to procure, a good or service from a person operating in the chemical or biological sectors of the economy of that country.”
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes or news coverage recorded for this bill yet.
Document Type
Congressional Bill
Official Title
CBW Fentanyl Act
Analysis generated by AI. Always verify with official sources.